Van ECK Associates Corp boosted its position in shares of Cabot Co. (NYSE:CBT - Free Report) by 40.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 31,549 shares of the specialty chemicals company's stock after buying an additional 9,014 shares during the quarter. Van ECK Associates Corp owned approximately 0.06% of Cabot worth $3,445,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in the company. Earnest Partners LLC raised its stake in shares of Cabot by 2.4% during the second quarter. Earnest Partners LLC now owns 3,363,398 shares of the specialty chemicals company's stock valued at $309,063,000 after acquiring an additional 80,096 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Cabot by 0.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,348,972 shares of the specialty chemicals company's stock valued at $123,965,000 after purchasing an additional 4,437 shares during the last quarter. American Century Companies Inc. lifted its holdings in Cabot by 7.3% in the 2nd quarter. American Century Companies Inc. now owns 976,709 shares of the specialty chemicals company's stock worth $89,750,000 after buying an additional 66,171 shares during the period. Sei Investments Co. grew its position in shares of Cabot by 5.9% in the 2nd quarter. Sei Investments Co. now owns 913,259 shares of the specialty chemicals company's stock worth $83,919,000 after buying an additional 51,178 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in shares of Cabot by 1.8% during the second quarter. Bank of New York Mellon Corp now owns 693,580 shares of the specialty chemicals company's stock valued at $63,733,000 after buying an additional 11,986 shares during the period. Hedge funds and other institutional investors own 93.18% of the company's stock.
Insider Activity at Cabot
In other news, EVP Jeff Ji Zhu sold 1,201 shares of the company's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $106.19, for a total value of $127,534.19. Following the transaction, the executive vice president now owns 96,000 shares in the company, valued at approximately $10,194,240. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other Cabot news, EVP Hobart Kalkstein sold 5,457 shares of the business's stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $100.58, for a total value of $548,865.06. Following the completion of the transaction, the executive vice president now owns 61,688 shares of the company's stock, valued at approximately $6,204,579.04. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Jeff Ji Zhu sold 1,201 shares of the firm's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $106.19, for a total transaction of $127,534.19. Following the sale, the executive vice president now directly owns 96,000 shares in the company, valued at approximately $10,194,240. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 48,665 shares of company stock valued at $4,986,299. 3.07% of the stock is owned by insiders.
Cabot Stock Down 1.4 %
Cabot stock traded down $1.61 on Friday, hitting $114.99. 522,848 shares of the stock traded hands, compared to its average volume of 362,496. The business's fifty day simple moving average is $109.13 and its 200 day simple moving average is $101.61. The firm has a market cap of $6.30 billion, a P/E ratio of 17.06, a price-to-earnings-growth ratio of 0.98 and a beta of 1.20. The company has a current ratio of 2.08, a quick ratio of 1.45 and a debt-to-equity ratio of 0.68. Cabot Co. has a 1 year low of $70.63 and a 1 year high of $117.46.
Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts' consensus estimates of $1.81 by ($0.01). The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $1.01 billion. Cabot had a return on equity of 26.60% and a net margin of 9.51%. The business's revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.65 earnings per share. As a group, sell-side analysts forecast that Cabot Co. will post 7.8 earnings per share for the current year.
Cabot Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, November 29th will be paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.50%. Cabot's payout ratio is 25.52%.
Analysts Set New Price Targets
Several analysts recently weighed in on the stock. Mizuho lifted their price target on shares of Cabot from $103.00 to $122.00 and gave the company an "outperform" rating in a report on Tuesday, November 5th. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $95.00 to $105.00 and gave the company a "neutral" rating in a research note on Wednesday, August 7th. Finally, UBS Group decreased their price target on shares of Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a research note on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $105.00.
Check Out Our Latest Report on Cabot
About Cabot
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report